Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development.

Porter et al. (2008) looked at 14 trials that added talk-therapy to mood pills for adults with bipolar disorder. They wanted to know which psychosocial extras best help people keep taking their meds.

The team pulled every RCT and cohort study they could find. They compared family sessions, group psychoeducation, and CBT as add-ons to usual pharmacotherapy.

No single add-on won. Psychoeducation, family work, and CBT all gave small but real boosts in pill-taking.

Because results were mixed, the review calls for smarter, tailor-made packages instead of one-size-fits-all programs.

Fujiura et al. (2018) echo the same vibe: a single 60-minute BA session helped rural HIV patients stick to HAART. Brief is possible, but effect sizes stayed modest, just like in bipolar trials.

Martens et al. (2019) extend the story into cognition. Their computerized memory training sharpened recall in one rapid-cycling bipolar patient, yet mood dipped mid-treatment. It shows psychosocial tools can target different domains, but gains remain shaky.

Johnson et al. (2025) flip the view to staff training. Teaching support workers about psychotropics raised knowledge, but no clear link to actual medication use appeared—another reminder that education alone rarely changes behavior.

For BCBAs, the paper says combine, don’t replace. Pair your behavior plan with brief psychoeducation or family sessions to nudge adherence. Track pill counts or pharmacy refill data weekly. If gains stall, pivot—layer in CBT modules or involve caregivers. One method won’t do it; a flexible mix gives you the best shot.